Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorac Cancer
Hauptverfasser: Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons Australia, Ltd 2019
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://ncbi.nlm.nih.gov/pubmed/30950239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13057
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge